Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axogen Inc (NQ: AXGN )

14.41 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Axogen Inc

< Previous 1 2 Next >
Axogen to Participate at Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Reports 2023 Second Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at Jefferies Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at JMP Securities Life Sciences Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Reports 2023 First Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
From Axogen, Inc.
Via GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
From Axogen, Inc.
Via GlobeNewswire
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including... 
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc Reports 2022 Third Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.
Dr. Tyndall is currently the Executive Vice President for Health Affairs and Dean of Morehouse School of Medicine. 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022
From Axogen, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.